发病机制
炎症
嗜酸性食管炎
疾病
肠道通透性
炎症性肠病
势垒函数
免疫学
脂肪肝
肝病
医学
病理
内科学
生物
细胞生物学
作者
Michael Camilleri,Adrian Vella
出处
期刊:Gut
[BMJ]
日期:2021-09-11
卷期号:71 (2): 424-435
被引量:79
标识
DOI:10.1136/gutjnl-2021-325428
摘要
### Key messages
The potential role of ‘leaky gut’ or reduced barrier function with increased intestinal permeability has been considered an important factor in intestinal and extraintestinal diseases. Reversing the impairment of barrier function in diseases associated with mucosal damage may be necessary but may not be sufficient to reverse the disease pathogenesis as in inflammatory bowel disease (IBD) or coeliac disease. In these diseases, the underlying immune dysfunction is likely to be a significant factor in perpetuating the disease. Nevertheless, gastrointestinal and extraintestinal diseases that are not associated with predominant inflammation in the small intestine or colon have drawn attention to the potential role of reduced barrier function in disease pathogenesis. These illnesses range from eosinophilic esophagitis to non-alcoholic fatty liver disease and to diverse neuropsychiatric diseases, as summarised elsewhere.1 There are also diverse systemic consequences associated with gut barrier dysfunction including increased inflammation or oxidative stress and decreased insulin sensitivity affecting tissues or organs such as the liver, fat, skeletal, muscle …
科研通智能强力驱动
Strongly Powered by AbleSci AI